Mom, I can't get my ADHD patch on! Shire [1] is recalling some lots of Daytrana, its attention deficit hyperactivity disorder patch--not because of safety issues, but because patients are having a hard time removing the release liner so they can administer the drug. The withdrawal is expected to cost the British drug maker some $10 million.
- see this release [2]
- here's the report [3] from MarketWatch
Related Articles:
FDA approves Daytrana ADHD patch [4]
FDA signals a quick approval for Shire's ADHD drug [5]
CDC estimates reignite ADHD controversy [6]
Links:
[1] http://www.fiercebiotech.com/story/shire-massachusetts-pass-incentive-bill-now/2007-08-31
[2] http://www.fiercebiotech.com/press-releases/press-release-shire-voluntarily-withdraws-limited-portion-daytrana-methylphenidate-tr
[3] http://www.marketwatch.com/news/story/shire-withdraws-some-daytrana-patches/story.aspx?guid=%7B55871E97%2DC53F%2D4863%2D82D8%2D3DB01A881765%7D&dist=hplatest
[4] http://www.fiercebiotech.com/story/fda-approves-daytrana-adhd-patch/2006-04-07
[5] http://www.fiercebiotech.com/story/fda-signals-a-quick-approval-for-shire-s-adhd-drug/2007-06-21?utm_source=related&utm_medium=internal
[6] http://www.fiercebiotech.com/story/spotlight-cdc-estimates-reignite-adhd-controversy/2006-05-25
